Pathophysiological Explorations of Red Blood Cells
NCT03541525 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3750
Last updated 2025-04-30
Summary
GR-Ex is a program labelled by Labex (Laboratory of Excellence) by the French Ministry of Higher Education and Research. This program aims to develop the means to improve knowledge in the physiology and pathologies of erythropoiesis, red blood cells and iron metabolism, and to develop new therapeutic protocols capable of providing added value in terms of innovation.
Conditions
- Red Blood Cell Disorder
Interventions
- OTHER
-
Biological sampling
Biological samples including blood, surgical remainder, urine,...
Sponsors & Collaborators
-
Imagine Institute
lead OTHER
Principal Investigators
-
Olivier Hermine, MD, PhD · Assistance Publique - Hôpitaux de Paris
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-16
- Primary Completion
- 2037-10-15
- Completion
- 2037-10-15
Countries
- Benin
- France
- Guadeloupe
Study Locations
More Related Trials
-
Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients
NCT01736657 ·Status: COMPLETED ·Phase: NA
-
Transfusion Exchanges and Cognition in Sickle Cell Disease
NCT07168447 ·Status: NOT_YET_RECRUITING
-
Evaluation of the AMICUS RBCx System in Sickle Cell Patients
NCT02372877 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Impact of Red Blood Cell Exchange on Thrombo-inflammation in Sickle Cell Disease
NCT06769139 ·Status: NOT_YET_RECRUITING
-
RH Genotype Matched RBC Transfusions
NCT04156893 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Collect of Cord Blood From Subjects at Risk for Sickle Cell Disease, for the Purpose of Laboratory Research
NCT03876821 ·Status: COMPLETED
-
Genomic Screening for Hereditary Erythrocytosis and Related Diseases
NCT03263364 ·Status: UNKNOWN
-
Peripheral Helper T-cells in Common Variable ImmunoDeficiency
NCT07255157 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia
NCT04053803 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Heart Arteries and Sickle Cell Disease / Coeur Artères DREpanocytose
NCT03114137 ·Status: UNKNOWN
-
Study of MGTA-145 and Plerixafor in Patients With Sickle Cell Disease
NCT05445128 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 Msec
NCT00879242 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Tolerance of Mobilizing Peripheral Hematopoietic Stem Cells by Plerixafor in Sickle Cell Patients
NCT02212535 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of IMR-687 in Healthy Adult Volunteers
NCT02998450 ·Status: COMPLETED ·Phase: PHASE1
-
Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients
NCT05255445 ·Status: COMPLETED
-
A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
NCT06985147 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of IMR-687 in Subjects With Beta Thalassemia
NCT04411082 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia
NCT00704353 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women
NCT01290315 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of IMR-687 in Subjects With Sickle Cell Disease
NCT04474314 ·Status: TERMINATED ·Phase: PHASE2
-
Registry of Congenital Dyserythropoietic Anemia
NCT03983629 ·Status: UNKNOWN
-
The Impact of Oxidative Stress on Erythrocyte Biology
NCT04028700 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate Efficacy and Safety of S303 Treated Red Blood Cells (RBCs)in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion
NCT01740531 ·Status: COMPLETED ·Phase: PHASE3
-
Biotin-Acridine Red Cell Exchange Kinetics
NCT07155031 ·Status: WITHDRAWN ·Phase: PHASE2
-
Immunopathology of Autoimmune Hemolytic Anemia
NCT02158195 ·Status: COMPLETED